Press Releases
Most people in favour of screening for spinal muscular atrophy
Research from the 91¸£Àû indicates that most people are in favour of newborn screening for the potentially deadly condition spinal muscular atrophy (SMA).
SMA is an inherited neuromuscular disorder with a wide spectrum of severities and is a leading genetic cause of infant death worldwide. However, there is no routine screening programme for SMA in the UK.
New TB drugs possible with understanding of old antibiotic
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the 91¸£Àû and The Francis Crick Institute.
‘Lost’ 99% of ocean microplastics to be identified with dye?
The smallest microplastics present in our oceans – which go largely undetected and are potentially harmful – could be more effectively identified using an innovative and inexpensive new method, developed by researchers at the 91¸£Àû.
Colon cancer breakthrough could lead to prevention
Colon cancer, Crohn’s, and other diseases of the gut could be better treated – or even prevented – thanks to a new link between inflammation and a common cellular process, established by the 91¸£Àû.
Crops evolving ten millennia before experts thought
Ancient hunter-gatherers began to systemically affect the evolution of crops up to thirty thousand years ago – around ten millennia before experts previously thought – according to new research by the 91¸£Àû.
VirionHealth Raises Series A Funding from Abingworth
91¸£Àû spin-out company, VirionHealth - a new biotechnology company developing novel therapeutics for respiratory viral infections, has raised £13m in Series A funding from Abingworth.